Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Ingredion Completes Sale of Business in South Korea
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
The New America High Income Fund, Inc. Declares Dividend
-
NADP Research Reveals Record in Dental Coverage for Americans
-
PIEDMONT OFFICE REALTY TRUST DECLARES FIRST QUARTER DIVIDEND
-
TC Transcontinental Printing to Close its Saint-Hyacinthe Plant
-
Post Holdings Reports Results for the First Quarter of Fiscal Year 2024; Raises Fiscal Year 2024 Outlook
-
Baker Hughes Declares Increased Quarterly Dividend
-
Coin Bureau Unveils Coin Bureau Club, a Premium Membership Offering for Crypto Enthusiasts
-
Crown Realty Partners Expands Portfolio With Acquisition of Atrium Building in Mississauga
-
Breakthrough Institute Endorses Bill to Improve Climate Data Coordination at USDA
-
ARCA biopharma Announces 2023 Financial Results
-
TriumphPay Announces Addition of Two New Hires to Sales Leadership Team
-
Advisory: Fortis Inc. to Hold Teleconference and Webcast on February 9 to Discuss 2023 Annual Results
-
Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024
-
Arvinas to Present at 6th Annual Guggenheim Biotechnology Conference
-
Glacier Bancorp Completes Acquisition of Community Financial Group, Inc. in Spokane, Washington
-
Southside Bancshares, Inc. Increases and Declares Cash Dividend
-
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
-
Guggenheim Investments Announces February 2024 Closed-End Fund Distributions
-
Travere Therapeutics to Present at the Guggenheim 6th Annual Biotechnology Conference
-
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis
-
Gray and Marquee Broadcasting Swap Television Station Assets
-
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024
-
Stem Holdings, Inc. Announces Effectiveness of Reverse Stock Split on February 1, 2024.
-
Trian Files Definitive Proxy Statement for Disney’s 2024 Annual Meeting and Recommends “Withhold” on Directors Michael B.G. Froman and Maria Elena Lagomasino
-
Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering
-
Enact Completes Forward XOL Reinsurance Transaction as Part of its Diversified Credit Risk Transfer Program
-
GMAT™ Focus Edition Stands Alone in Business School Assessment as Previous Version Sunsets
-
DTE Energy issues dividend
-
Worthington Enterprises Acquires HALO Products Brand
-
Mercury Awarded Subcontract for the U.S. Army’s Next-Generation LTAMDS Radar System
-
ARMOUR Residential REIT, Inc. Announces February 2024 Dividend Rate Per Common Share and Tax Allocation for 2023 Dividends
-
TopBuild to Acquire Pest Control Insulation
-
Cipher Mining Announces January 2024 Operational Update
-
AMN Healthcare to Hold Fourth Quarter and Full Year 2023 Earnings Conference Call on Thursday, February 15, 2024
-
Matthews International Reports Results for Fiscal 2024 First Quarter
-
Microchip Technology Announces Financial Results for Third Quarter of Fiscal Year 2024
-
AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
-
Microchip Technology Increases Quarterly Cash Dividend 25.7% Year-Over-Year to 45.0 Cents Per Share
-
Applied Optoelectronics Announces Date of Fourth Quarter and Full Year 2023 Financial Results Conference Call
-
Okeanis Eco Tankers Corp. – New Financings Update
-
The Ensign Group Reports Fiscal Year and Fourth Quarter 2023 Results; Issues 2024 Earnings Guidance
-
TPI Composites, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
-
Vaxcyte to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
-
CNB Financial Corporation Announces Quarterly Dividend for Series A Preferred Stock and Related Depositary Shares Distribution
-
Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
-
seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting
-
Leslie’s, Inc. Announces First Quarter Fiscal 2024 Financial Results
-
Pathfinder Bancorp, Inc. Announces Fourth Quarter 2023 Net Income of $2.5 Million and Full Year Net Income of $9.3 Million
